296 related articles for article (PubMed ID: 25928084)
21. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional master regulator analysis in breast cancer genetic networks.
Tovar H; García-Herrera R; Espinal-Enríquez J; Hernández-Lemus E
Comput Biol Chem; 2015 Dec; 59 Pt B():67-77. PubMed ID: 26362298
[TBL] [Abstract][Full Text] [Related]
23. Array-based DNA methylation profiling for breast cancer subtype discrimination.
Van der Auwera I; Yu W; Suo L; Van Neste L; van Dam P; Van Marck EA; Pauwels P; Vermeulen PB; Dirix LY; Van Laere SJ
PLoS One; 2010 Sep; 5(9):e12616. PubMed ID: 20830311
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.
Bertucci F; Finetti P; Rougemont J; Charafe-Jauffret E; Cervera N; Tarpin C; Nguyen C; Xerri L; Houlgatte R; Jacquemier J; Viens P; Birnbaum D
Cancer Res; 2005 Mar; 65(6):2170-8. PubMed ID: 15781628
[TBL] [Abstract][Full Text] [Related]
25. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
27. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
Allen SG; Chen YC; Madden JM; Fournier CL; Altemus MA; Hiziroglu AB; Cheng YH; Wu ZF; Bao L; Yates JA; Yoon E; Merajver SD
Sci Rep; 2016 Dec; 6():39190. PubMed ID: 27991524
[TBL] [Abstract][Full Text] [Related]
28. Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis.
Van Laere S; Van der Auwera I; Van den Eynden G; Van Hummelen P; van Dam P; Van Marck E; Vermeulen PB; Dirix L
Br J Cancer; 2007 Oct; 97(8):1165-74. PubMed ID: 17848951
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
Charafe-Jauffret E; Tarpin C; Bardou VJ; Bertucci F; Ginestier C; Braud AC; Puig B; Geneix J; Hassoun J; Birnbaum D; Jacquemier J; Viens P
J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
[TBL] [Abstract][Full Text] [Related]
30. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.
Manai M; ELBini-Dhouib I; Finetti P; Bichiou H; Reduzzi C; Aissaoui D; Ben-Hamida N; Agavnian E; Srairi-Abid N; Lopez M; Amri F; Guizani-Tabbane L; Rahal K; Mrad K; Manai M; Birnbaum D; Mamessier E; Cristofanilli M; Boussen H; Kharrat M; Doghri R; Bertucci F
Cells; 2022 Sep; 11(18):. PubMed ID: 36139501
[TBL] [Abstract][Full Text] [Related]
31. Systematically identify key genes in inflammatory and non-inflammatory breast cancer.
Chai F; Liang Y; Zhang F; Wang M; Zhong L; Jiang J
Gene; 2016 Jan; 575(2 Pt 3):600-14. PubMed ID: 26403314
[TBL] [Abstract][Full Text] [Related]
32. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.
Van Laere S; Van der Auwera I; Van den Eynden GG; Fox SB; Bianchi F; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2005 Oct; 93(3):237-46. PubMed ID: 16172796
[TBL] [Abstract][Full Text] [Related]
33. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
[TBL] [Abstract][Full Text] [Related]
34. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.
Iwamoto T; Bianchini G; Qi Y; Cristofanilli M; Lucci A; Woodward WA; Reuben JM; Matsuoka J; Gong Y; Krishnamurthy S; Valero V; Hortobagyi GN; Robertson F; Symmans WF; Pusztai L; Ueno NT
Breast Cancer Res Treat; 2011 Feb; 125(3):785-95. PubMed ID: 21153052
[TBL] [Abstract][Full Text] [Related]
35. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
[TBL] [Abstract][Full Text] [Related]
36. Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.
Nguyen DM; Sam K; Tsimelzon A; Li X; Wong H; Mohsin S; Clark GM; Hilsenbeck SG; Elledge RM; Allred DC; O'Connell P; Chang JC
Clin Cancer Res; 2006 Sep; 12(17):5047-54. PubMed ID: 16951220
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
Van Laere SJ; Van der Auwera I; Van den Eynden GG; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2007 Sep; 97(5):659-69. PubMed ID: 17700572
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
39. Identifying cancer biomarkers by network-constrained support vector machines.
Chen L; Xuan J; Riggins RB; Clarke R; Wang Y
BMC Syst Biol; 2011 Oct; 5():161. PubMed ID: 21992556
[TBL] [Abstract][Full Text] [Related]
40. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer.
Provance OK; Lewis-Wambi J
Breast Cancer Res; 2019 May; 21(1):59. PubMed ID: 31060575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
